A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma

Janice P. Dutcher, Ellen R. Gaynor, David H. Boldt, James H. Doroshow, Michael H. Bar, Mario Sznol, James Mier, Joseph Sparano, Richard I. Fisher, Geoffrey Weiss, Kim Margolin, Frederick R. Aronson, Michael Hawkins, Michael Atkins

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences